Send to a Friend Font Size: Increase Decrease

PRLD and INCY Related Headlines

Nov 4, 2025 07:01AM Prelude Therapeutics secures $60M from Incyte option deal
Nov 4, 2025 07:01AM Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

PRLD and INCY Related Press Releases

Nov 4, 2025 07:01AM Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

PRLD and INCY Related SEC Filings